Additionally, in vivo experiments using a xenograft mouse model revealed that inhibition of USP13 notably reduced tumor growth, while increasing CD8 + T cell infiltration and boosting GZMB and IFN-γ secretion in tumor tissues, thus enhancing T cell activity. The gene discussed is USP13; the disease is neoplasm.